Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study
Rule, Simon, Barreto, Wolney Gois, Briones, Javier, Carella, Angelo M, Casasnovas, Olivier, Pocock, Chris, Wendtner, Clemens-Martin, Zaja, Francesco, Robson, Susan, MacGregor, Lachlan, Tschopp, Roger R, Nick, Sonja, Dreyling, Martin
Published in Haematologica (Roma) (01.02.2022)
Published in Haematologica (Roma) (01.02.2022)
Get full text
Journal Article
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study
Leblond, Véronique, Aktan, Melih, Ferra Coll, Christelle M, Dartigeas, Caroline, Kisro, Jens, Montillo, Marco, Raposo, João, Merot, Jean-Louis, Robson, Susan, Gresko, Ekaterina, Bosch, Francesc, Stilgenbauer, Stephan, Foà, Robin
Published in Haematologica (Roma) (01.11.2018)
Published in Haematologica (Roma) (01.11.2018)
Get full text
Journal Article
Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
Castaman, Giancarlo, Peyvandi, Flora, Kremer Hovinga, Johanna A, Schutgens, Roger E G, Robson, Susan, Moreno, Katya, Jiménez-Yuste, Víctor
Published in TH open : companion journal to thrombosis and haemostasis (01.01.2024)
Published in TH open : companion journal to thrombosis and haemostasis (01.01.2024)
Get full text
Journal Article
Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis
Castaman, Giancarlo, Windyga, Jerzy, Alzahrani, Hazza, Robson, Susan, Sanabria, Fabian, Howard, Monet, Jiménez-Yuste, Víctor
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Everybody should have access to occupational health services
Raynal, Anne, Hermanns, Robert, Robson, Susan, Weir, Mark, Carry, Daniel
Published in BMJ (Online) (09.01.2019)
Published in BMJ (Online) (09.01.2019)
Get full text
Journal Article
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Stilgenbauer, Stephan, Leblond, Veronique, Foà, Robin, Böttcher, Sebastian, Ilhan, Osman, Knauf, Wolfgang, Mikuskova, Eva, Renner, Christoph, Tausch, Eugen, Woszczyk, Dariusz, Gresko, Ekaterina, Lundberg, Linda, Moore, Tom, Morris, Thea, Robson, Susan, Bosch, Francesc
Published in Leukemia (01.08.2018)
Published in Leukemia (01.08.2018)
Get full text
Journal Article
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
Bosch, Francesc, Cantin, Guy, Cortelezzi, Agostino, Knauf, Wolfgang, Tiab, Mourad, Turgut, Mehmet, Zaritskey, Andrey, Merot, Jean-Louis, Tausch, Eugen, Trunzer, Kerstin, Robson, Susan, Gresko, Ekaterina, Böttcher, Sebastian, Foà, Robin, Stilgenbauer, Stephan, Leblond, Véronique
Published in Leukemia (01.02.2020)
Published in Leukemia (01.02.2020)
Get full text
Journal Article
Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study
Bosch, Francesc, Foà, Robin, Cortelezzi, Agostino, Kisro, Jens, Leblond, Veronique, Tumyan, Gayane, Gresko, Ekaterina, Robson, Susan, Stilgenbauer, Stephan
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY)
Jiménez‐Yuste, Víctor, Peyvandi, Flora, Klamroth, Robert, Castaman, Giancarlo, Shanmukhaiah, Chandrakala, Rangarajan, Savita, García Chavez, Jaime, Martinez, Raul, Kenet, Gili, Alzahrani, Hazaa, Robson, Susan, Schmitt, Christophe, Kiialainen, Anna, Meier, Oliver, Ozelo, Margareth
Published in Research and practice in thrombosis and haemostasis (01.11.2022)
Published in Research and practice in thrombosis and haemostasis (01.11.2022)
Get full text
Journal Article
Safety of Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Results from the Primary Analysis of the Phase 3b GREEN Study
Stilgenbauer, Stephan, Aktan, Melih, Ferra Coll, Christelle M, Dartigeas, Caroline, Kisro, Jens, Montillo, Marco, Raposo, João, Merot, Jean-Louis, Robson, Susan, Gresko, Ekaterina, Bosch, Francesc, Foà, Robin, Leblond, Véronique
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials
Klanova, Magdalena, Oestergaard, Mikkel Z., Trněný, Marek, Hiddemann, Wolfgang, Marcus, Robert, Sehn, Laurie H., Vitolo, Umberto, Bazeos, Alexandra, Goede, Valentin, Zeuner, Harald, Knapp, Andrea, Sahin, Denis, Danesi, Nathalie, Bolen, Christopher, Robson, Susan, Venstrom, Jeffrey M., Nielsen, Tina, Fingerle-Rowson, Günter
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study
Leblond, Veronique, Cantin, Guy, Cortelezzi, Agostino, Knauf, Wolfgang, Tiab, Mourad, Turgut, Mehmet, Zaritskey, Andrey, Merot, Jean-Louis, Trunzer, Kerstin, Robson, Susan, Gresko, Ekaterina, Stilgenbauer, Stephan, Foà, Robin, Bosch, Francesc
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Mapping dominant annual land cover from 2009 to 2013 across Victoria, Australia using satellite imagery
Sheffield, Kathryn, Morse-McNabb, Elizabeth, Clark, Rob, Robson, Susan, Lewis, Hayden
Published in Scientific data (24.11.2015)
Published in Scientific data (24.11.2015)
Get full text
Journal Article
Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF^sup V600^ mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis
Blank, Christian U, Larkin, James, Arance, Ana M, Hauschild, Axel, Queirolo, Paola, Del Vecchio, Michele, Ascierto, Paolo A, Krajsova, Ivana, Schachter, Jacob, Neyns, Bart, Garbe, Claus, Sileni, Vanna Chiarion, Mandalà, Mario, Gogas, Helen, Espinosa, Enrique, Hospers, Geke AP, Miller, Wilson H, Robson, Susan, Makrutzki, Martina, Antic, Vladan, Brown, Michael P
Published in European journal of cancer (1990) (01.07.2017)
Get full text
Published in European journal of cancer (1990) (01.07.2017)
Journal Article